How the FDA Handles GI Drug Safety

被引：0

作者：

Lewis, James H. ^{[1
]}

机构：

[1] Georgetown Univ, Div Gastroenterol, Med Ctr, Washington, DC 20007 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷 / 08期

关键词：

ISCHEMIC COLITIS; RISK;

D O I：

10.1038/ajg.2012.175

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1264 / 1264

页数：1

共 50 条

[21] FDA alerts asthmatics to drug safety risk
Clare Ellis
Nature Reviews Drug Discovery, 2003, 2 : 765 - 765
[22] FDA's role in drug safety.
Graham, D.
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S93 - S93
[23] How the FDA Manages Drug Safety With Black Box Warnings, Use Restrictions, and Drug Removal, With Attention to Gastrointestinal Medications
Ehrenpreis, Eli D.
Ciociola, Arthur A.
Kulkarni, Prasad M.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (04): : 501 - 504
[24] FDA drug labeling for pregnancy and lactation drug safety monitoring systems
Greene, Michael F.
SEMINARS IN PERINATOLOGY, 2015, 39 (07) : 520 - 523
[25] Post-market drug safety evidence sources: an analysis of FDA drug safety communications
Ishiguro, Chieko
Hall, Marni
Neyarapally, George A.
Dal Pan, Gerald
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (10) : 1134 - 1136
[26] Post-marketing drug safety sources: An evaluation of the FDA's drug safety communications
Aldayel, Atheer
Alghamdi, Maha
Almutairi, Abdulaali
Al-Harbi, Fawaz F.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 302 - 302
[27] US FDA reports new steps in drug safety
Reactions Weekly, 2007, 1138 (1) : 3 - 3
[28] Bolstering the FDA's drug-safety authority
Schultz, William B.
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22): : 2217 - 2219
[29] FDA under pressure of address drug safety issues
Wechsler, J
BIOPHARM INTERNATIONAL, 2005, 18 (02) : 16 - 17
[30] FDA Sets Policies to Enhance Drug Security and Safety
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2015, 28 (02) : 10 - 11

← 1 2 3 4 5 →